Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Secondary infections - Covid -19
View:
Post by mercedesman on Jan 12, 2021 12:33pm

Secondary infections - Covid -19

From the Italian Study

"54% of patients admitted to the ICU developed an
infection, which was due to gram-negative microorganisms in 67% of the cases."


This would seem to imply (through extrapolation and basic math) that  more than 1/3 of Covid-19 patients develop gram-negative, sepsis like infections.

2 Million have died form Covid-19 so far.

Closing in on 400,000 in the US alone.  Implyinig that perhaps 120,000 may have been able to benefit from a PMX treatment? 

Isn't that double our normal targeted popultion of Severe Sepsis patients?

What happens to a stock price when you double the revenue?

MM
Comment by mercedesman on Jan 12, 2021 9:30pm
Apologies again ... for another potential understatement on PMX usefulness as a Covid treatment.  current mortality rate in US 4000/day. Next  Six months  only  = 730,000 1/3  = 243,000 ( gram negative infections with elevated endotoxins)  yes vaccines will start to take effect end of Q1, but offset by rising death rate and more contagious strains taking hold ...more  
Comment by SouthernTierTom on Jan 12, 2021 10:25pm
Thanks for the math...whilst we compare our value to other true "start-ups" in the Canadien bio-game...it would appear we are severely undervalued or others are laughably over-valued...I've always been a "sister golden hare" kind of person..."meat me in the middle" type...at 79 MILLION USD we seem like good value... Canadian OTC SONA, a covid19 rabbit has failed ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities